Inpharma Weekly

, Volume 1032, Issue 1, pp 3–4 | Cite as

Immunogens and genes put to use as hair therapy

  • Sean Henahan
Newsletter Article


Topical immunotherapy may offer the best hope for patients with various forms of baldness including alopecia areata and chemotherapy-induced hair loss, reported researchers at an IBC USA conference on Immunobiological and Genetic Approaches for the Treatment of Alopecia and other Hair Disorders [ San Diego, US; March 1996 ]. The results of the largest study to date of topical immunotherapy with diphenylcyclopropenone (DPCP) as a treatment for hair loss were presented at the conference. Responses were seen in ≪ 50% of patients receiving this form of immunotherapy.


Hair Follicle Contact Dermatitis Hair Loss Alopecia Areata Contact Sensitiser 

Copyright information

© Adis International Ltd 1996

Authors and Affiliations

  • Sean Henahan

There are no affiliations available

Personalised recommendations